N C Moran. Show Affiliations »
Abstract
Mesh: See more » Adrenergic alpha-Antagonists/pharmacologyAdrenergic alpha-Antagonists/therapeutic useAdrenergic beta-Antagonists/pharmacologyAdrenergic beta-Antagonists/therapeutic useAngiotensin II/pharmacologyAngiotensin II/therapeutic useBlood Vessels/drug effectsDigitalis Glycosides/pharmacologyDigitalis Glycosides/therapeutic useDopamine/pharmacologyDopamine/therapeutic useEpinephrine/pharmacologyEpinephrine/therapeutic useGlucocorticoids/pharmacologyGlucocorticoids/therapeutic useHeart/drug effectsHumansMephentermine/pharmacologyMephentermine/therapeutic useNorepinephrine/pharmacologyNorepinephrine/therapeutic useRegional Blood Flow/drug effectsShock, Cardiogenic/drug therapySympatholytics/pharmacologySympatholytics/therapeutic useSympathomimetics/pharmacologySympathomimetics/therapeutic useVasoconstrictor Agents/pharmacologyVasoconstrictor Agents/therapeutic useVasodilator Agents/pharmacologyVasodilator Agents/therapeutic use
Substances: See more » Adrenergic alpha-AntagonistsAdrenergic beta-AntagonistsDigitalis GlycosidesGlucocorticoidsSympatholyticsSympathomimeticsVasoconstrictor AgentsVasodilator AgentsAngiotensin IIMephentermineDopamineNorepinephrineEpinephrine
Year: 1970 PMID: 4398718 DOI: 10.1016/0002-9149(70)90409-1
Source DB: PubMed Journal: Am J Cardiol ISSN: 0002-9149 Impact factor: 2.778